avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Stat2
|
ENSMUSG00000040033.9 | signal transducer and activator of transcription 2 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Stat2 | mm10_v2_chr10_+_128270546_128270577 | 0.71 | 1.0e-06 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr15_+_77729091 | 12.27 |
ENSMUST00000109775.2
|
Apol9b
|
apolipoprotein L 9b |
chr6_+_41521782 | 9.31 |
ENSMUST00000070380.4
|
Prss2
|
protease, serine, 2 |
chr15_-_77411034 | 8.03 |
ENSMUST00000089452.5
ENSMUST00000081776.3 |
Apol9a
|
apolipoprotein L 9a |
chr7_-_141010759 | 7.50 |
ENSMUST00000026565.6
|
Ifitm3
|
interferon induced transmembrane protein 3 |
chr1_+_130826762 | 6.94 |
ENSMUST00000133792.1
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_130826676 | 6.61 |
ENSMUST00000027675.7
|
Pigr
|
polymeric immunoglobulin receptor |
chr1_+_167618246 | 6.59 |
ENSMUST00000111380.1
|
Rxrg
|
retinoid X receptor gamma |
chr10_+_40629987 | 6.31 |
ENSMUST00000019977.7
|
Ddo
|
D-aspartate oxidase |
chr6_+_41392356 | 6.24 |
ENSMUST00000049079.7
|
Gm5771
|
predicted gene 5771 |
chr4_-_42756543 | 6.04 |
ENSMUST00000102957.3
|
Ccl19
|
chemokine (C-C motif) ligand 19 |
chr16_+_26581704 | 5.76 |
ENSMUST00000096129.2
ENSMUST00000166294.2 ENSMUST00000174202.1 ENSMUST00000023156.6 |
Il1rap
|
interleukin 1 receptor accessory protein |
chr19_-_11050500 | 5.75 |
ENSMUST00000099676.4
|
AW112010
|
expressed sequence AW112010 |
chr4_+_42629719 | 5.71 |
ENSMUST00000166898.2
|
Gm2564
|
predicted gene 2564 |
chr2_-_173218879 | 5.57 |
ENSMUST00000109116.2
ENSMUST00000029018.7 |
Zbp1
|
Z-DNA binding protein 1 |
chr6_+_41458923 | 5.49 |
ENSMUST00000031910.7
|
Prss1
|
protease, serine, 1 (trypsin 1) |
chr19_+_34583528 | 5.29 |
ENSMUST00000102825.3
|
Ifit3
|
interferon-induced protein with tetratricopeptide repeats 3 |
chr19_+_34607927 | 5.21 |
ENSMUST00000076249.5
|
I830012O16Rik
|
RIKEN cDNA I830012O16 gene |
chr8_-_45333189 | 5.05 |
ENSMUST00000095328.4
|
Cyp4v3
|
cytochrome P450, family 4, subfamily v, polypeptide 3 |
chr12_+_104406704 | 4.93 |
ENSMUST00000021506.5
|
Serpina3n
|
serine (or cysteine) peptidase inhibitor, clade A, member 3N |
chr19_+_34640871 | 4.71 |
ENSMUST00000102824.3
|
Ifit1
|
interferon-induced protein with tetratricopeptide repeats 1 |
chr18_+_60212080 | 4.69 |
ENSMUST00000031549.5
|
Gm4951
|
predicted gene 4951 |
chr4_+_42114817 | 4.47 |
ENSMUST00000098123.3
|
Gm13304
|
predicted gene 13304 |
chr16_+_43363855 | 4.31 |
ENSMUST00000156367.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr4_+_41903610 | 4.29 |
ENSMUST00000098128.3
|
Gm21541
|
predicted gene, 21541 |
chr14_+_41105359 | 4.15 |
ENSMUST00000047286.6
|
Mat1a
|
methionine adenosyltransferase I, alpha |
chr19_-_46148369 | 4.05 |
ENSMUST00000026259.9
|
Pitx3
|
paired-like homeodomain transcription factor 3 |
chr8_+_107150621 | 4.02 |
ENSMUST00000034400.3
|
Cyb5b
|
cytochrome b5 type B |
chr4_-_42773993 | 3.98 |
ENSMUST00000095114.4
|
Ccl21a
|
chemokine (C-C motif) ligand 21A (serine) |
chr10_+_87860030 | 3.91 |
ENSMUST00000062862.6
|
Igf1
|
insulin-like growth factor 1 |
chr4_+_42255767 | 3.87 |
ENSMUST00000178864.1
|
Ccl21b
|
chemokine (C-C motif) ligand 21B (leucine) |
chr6_-_23839137 | 3.77 |
ENSMUST00000166458.2
ENSMUST00000142913.2 ENSMUST00000115357.1 ENSMUST00000069074.7 ENSMUST00000115361.2 ENSMUST00000018122.7 ENSMUST00000115355.1 ENSMUST00000115356.2 |
Cadps2
|
Ca2+-dependent activator protein for secretion 2 |
chr11_+_70459940 | 3.76 |
ENSMUST00000147289.1
ENSMUST00000126105.1 |
Zmynd15
|
zinc finger, MYND-type containing 15 |
chr5_+_114923234 | 3.70 |
ENSMUST00000031540.4
ENSMUST00000112143.3 |
Oasl1
|
2'-5' oligoadenylate synthetase-like 1 |
chr16_+_23609895 | 3.67 |
ENSMUST00000038423.5
|
Rtp4
|
receptor transporter protein 4 |
chr5_-_139814025 | 3.44 |
ENSMUST00000146780.1
|
Tmem184a
|
transmembrane protein 184a |
chr11_-_83530505 | 3.31 |
ENSMUST00000035938.2
|
Ccl5
|
chemokine (C-C motif) ligand 5 |
chr11_-_48992226 | 3.24 |
ENSMUST00000059930.2
ENSMUST00000068063.3 |
Gm12185
Tgtp1
|
predicted gene 12185 T cell specific GTPase 1 |
chr3_-_151749877 | 3.20 |
ENSMUST00000029671.7
|
Ifi44
|
interferon-induced protein 44 |
chr8_-_71537402 | 3.13 |
ENSMUST00000051672.7
|
Bst2
|
bone marrow stromal cell antigen 2 |
chr6_+_90550789 | 3.12 |
ENSMUST00000130418.1
ENSMUST00000032175.8 |
Aldh1l1
|
aldehyde dehydrogenase 1 family, member L1 |
chr15_-_77596110 | 3.08 |
ENSMUST00000089465.4
|
Apol10b
|
apolipoprotein L 10B |
chr2_+_155382186 | 3.06 |
ENSMUST00000134218.1
|
Trp53inp2
|
transformation related protein 53 inducible nuclear protein 2 |
chr1_-_173490933 | 2.97 |
ENSMUST00000160565.2
|
Gm4955
|
predicted gene 4955 |
chr9_-_48835932 | 2.91 |
ENSMUST00000093852.3
|
Zbtb16
|
zinc finger and BTB domain containing 16 |
chr16_-_35871544 | 2.89 |
ENSMUST00000042665.8
|
Parp14
|
poly (ADP-ribose) polymerase family, member 14 |
chr15_-_77533312 | 2.75 |
ENSMUST00000062562.5
|
Apol7c
|
apolipoprotein L 7c |
chr9_-_106476590 | 2.75 |
ENSMUST00000112479.2
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr9_-_106476104 | 2.74 |
ENSMUST00000156426.1
|
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr3_+_81932601 | 2.72 |
ENSMUST00000029649.2
|
Ctso
|
cathepsin O |
chr16_+_43235856 | 2.65 |
ENSMUST00000146708.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr11_+_58215028 | 2.65 |
ENSMUST00000108836.1
|
Irgm2
|
immunity-related GTPase family M member 2 |
chr14_-_7994563 | 2.58 |
ENSMUST00000026315.7
|
Dnase1l3
|
deoxyribonuclease 1-like 3 |
chr11_+_58199556 | 2.56 |
ENSMUST00000035266.4
ENSMUST00000094169.4 ENSMUST00000168280.1 ENSMUST00000058704.8 |
Igtp
Irgm2
|
interferon gamma induced GTPase immunity-related GTPase family M member 2 |
chr17_+_34187545 | 2.55 |
ENSMUST00000170086.1
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr3_+_142560052 | 2.54 |
ENSMUST00000106222.2
|
Gbp3
|
guanylate binding protein 3 |
chr1_-_173599074 | 2.53 |
ENSMUST00000150649.1
ENSMUST00000180215.1 ENSMUST00000097462.2 |
Pydc4
|
pyrin domain containing 4 |
chr3_+_142560108 | 2.50 |
ENSMUST00000128609.1
ENSMUST00000029935.7 |
Gbp3
|
guanylate binding protein 3 |
chr4_-_46536096 | 2.49 |
ENSMUST00000102924.2
|
Trim14
|
tripartite motif-containing 14 |
chr3_+_142560351 | 2.47 |
ENSMUST00000106221.1
|
Gbp3
|
guanylate binding protein 3 |
chr9_-_106476372 | 2.46 |
ENSMUST00000123555.1
ENSMUST00000125850.1 |
Parp3
|
poly (ADP-ribose) polymerase family, member 3 |
chr10_+_116301374 | 2.46 |
ENSMUST00000092167.5
|
Ptprb
|
protein tyrosine phosphatase, receptor type, B |
chr18_-_3299537 | 2.44 |
ENSMUST00000129435.1
ENSMUST00000122958.1 |
Crem
|
cAMP responsive element modulator |
chr17_-_34862122 | 2.40 |
ENSMUST00000154526.1
|
Cfb
|
complement factor B |
chr6_+_121245903 | 2.40 |
ENSMUST00000032198.9
|
Usp18
|
ubiquitin specific peptidase 18 |
chr17_+_34187789 | 2.37 |
ENSMUST00000041633.8
|
Tap1
|
transporter 1, ATP-binding cassette, sub-family B (MDR/TAP) |
chr4_-_46536134 | 2.37 |
ENSMUST00000046897.6
|
Trim14
|
tripartite motif-containing 14 |
chr7_-_141266415 | 2.29 |
ENSMUST00000106023.1
ENSMUST00000097952.2 ENSMUST00000026571.4 |
Irf7
|
interferon regulatory factor 7 |
chr1_+_173673651 | 2.27 |
ENSMUST00000085876.4
|
Pydc3
|
pyrin domain containing 3 |
chr7_+_107567445 | 2.25 |
ENSMUST00000120990.1
|
Olfml1
|
olfactomedin-like 1 |
chr5_-_139813237 | 2.22 |
ENSMUST00000110832.1
|
Tmem184a
|
transmembrane protein 184a |
chr17_-_34862473 | 2.22 |
ENSMUST00000025229.4
ENSMUST00000176203.2 ENSMUST00000128767.1 |
Cfb
|
complement factor B |
chr16_-_24393588 | 2.20 |
ENSMUST00000181640.1
|
1110054M08Rik
|
RIKEN cDNA 1110054M08 gene |
chr16_+_10488175 | 2.19 |
ENSMUST00000023147.6
|
Ciita
|
class II transactivator |
chr11_-_70459957 | 2.15 |
ENSMUST00000019064.2
|
Cxcl16
|
chemokine (C-X-C motif) ligand 16 |
chr2_-_36104060 | 2.10 |
ENSMUST00000112961.3
ENSMUST00000112966.3 |
Lhx6
|
LIM homeobox protein 6 |
chr7_-_104507812 | 2.09 |
ENSMUST00000033211.7
ENSMUST00000071069.6 |
Trim30d
|
tripartite motif-containing 30D |
chr17_-_34187219 | 2.08 |
ENSMUST00000173831.1
|
Psmb9
|
proteasome (prosome, macropain) subunit, beta type 9 (large multifunctional peptidase 2) |
chr4_+_108834601 | 2.07 |
ENSMUST00000030296.8
|
Txndc12
|
thioredoxin domain containing 12 (endoplasmic reticulum) |
chr14_-_11162008 | 2.03 |
ENSMUST00000162278.1
ENSMUST00000160340.1 ENSMUST00000160956.1 |
Fhit
|
fragile histidine triad gene |
chr12_+_103434211 | 1.95 |
ENSMUST00000079294.5
ENSMUST00000076788.5 ENSMUST00000076702.5 ENSMUST00000066701.6 ENSMUST00000085065.5 ENSMUST00000140838.1 |
Ifi27
|
interferon, alpha-inducible protein 27 |
chr2_-_181241955 | 1.93 |
ENSMUST00000121484.1
|
Helz2
|
helicase with zinc finger 2, transcriptional coactivator |
chr1_+_175631996 | 1.92 |
ENSMUST00000040250.8
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr3_+_19957088 | 1.92 |
ENSMUST00000108328.1
|
Cp
|
ceruloplasmin |
chr11_-_100704217 | 1.92 |
ENSMUST00000017974.6
|
Dhx58
|
DEXH (Asp-Glu-X-His) box polypeptide 58 |
chr18_-_39489880 | 1.88 |
ENSMUST00000152853.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr1_+_52119438 | 1.87 |
ENSMUST00000070968.7
|
Stat1
|
signal transducer and activator of transcription 1 |
chr2_+_122147680 | 1.87 |
ENSMUST00000102476.4
|
B2m
|
beta-2 microglobulin |
chr2_-_181242020 | 1.87 |
ENSMUST00000094203.4
ENSMUST00000108831.1 |
Helz2
|
helicase with zinc finger 2, transcriptional coactivator |
chr11_-_48871408 | 1.86 |
ENSMUST00000097271.2
|
Irgm1
|
immunity-related GTPase family M member 1 |
chr18_-_3299452 | 1.86 |
ENSMUST00000126578.1
|
Crem
|
cAMP responsive element modulator |
chr2_-_167062607 | 1.84 |
ENSMUST00000128676.1
|
Znfx1
|
zinc finger, NFX1-type containing 1 |
chr2_-_62646146 | 1.83 |
ENSMUST00000112459.3
ENSMUST00000028259.5 |
Ifih1
|
interferon induced with helicase C domain 1 |
chr1_+_175632169 | 1.80 |
ENSMUST00000097458.3
|
Kmo
|
kynurenine 3-monooxygenase (kynurenine 3-hydroxylase) |
chr1_-_105356658 | 1.79 |
ENSMUST00000058688.5
ENSMUST00000172299.1 |
Rnf152
|
ring finger protein 152 |
chr16_+_43364145 | 1.79 |
ENSMUST00000148775.1
|
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr1_+_13668739 | 1.76 |
ENSMUST00000088542.3
|
Xkr9
|
X Kell blood group precursor related family member 9 homolog |
chr5_-_91402905 | 1.75 |
ENSMUST00000121044.2
|
Btc
|
betacellulin, epidermal growth factor family member |
chr3_+_19957037 | 1.70 |
ENSMUST00000091309.5
ENSMUST00000108329.1 ENSMUST00000003714.6 |
Cp
|
ceruloplasmin |
chr7_-_126594941 | 1.66 |
ENSMUST00000058429.5
|
Il27
|
interleukin 27 |
chr14_+_28511344 | 1.62 |
ENSMUST00000112272.1
|
Wnt5a
|
wingless-related MMTV integration site 5A |
chr12_+_37241729 | 1.61 |
ENSMUST00000160768.1
|
Agmo
|
alkylglycerol monooxygenase |
chr11_+_48978889 | 1.58 |
ENSMUST00000179282.1
ENSMUST00000056759.4 |
Olfr56
|
olfactory receptor 56 |
chr6_-_39118211 | 1.57 |
ENSMUST00000038398.6
|
Parp12
|
poly (ADP-ribose) polymerase family, member 12 |
chr3_+_55116174 | 1.57 |
ENSMUST00000146109.1
|
Spg20
|
spastic paraplegia 20, spartin (Troyer syndrome) homolog (human) |
chr3_+_19957240 | 1.56 |
ENSMUST00000108325.2
|
Cp
|
ceruloplasmin |
chr5_-_120887582 | 1.55 |
ENSMUST00000086368.5
|
Oas1g
|
2'-5' oligoadenylate synthetase 1G |
chr11_-_78984946 | 1.55 |
ENSMUST00000108268.3
|
Lgals9
|
lectin, galactose binding, soluble 9 |
chr19_-_4477447 | 1.52 |
ENSMUST00000059295.3
|
Syt12
|
synaptotagmin XII |
chr4_+_135728116 | 1.52 |
ENSMUST00000102546.3
|
Il22ra1
|
interleukin 22 receptor, alpha 1 |
chr11_-_78984831 | 1.52 |
ENSMUST00000073001.4
ENSMUST00000108269.3 |
Lgals9
|
lectin, galactose binding, soluble 9 |
chr11_+_119393060 | 1.49 |
ENSMUST00000131035.2
ENSMUST00000093902.5 |
Rnf213
|
ring finger protein 213 |
chr11_+_72301613 | 1.48 |
ENSMUST00000151440.1
ENSMUST00000146233.1 ENSMUST00000140842.2 |
Xaf1
|
XIAP associated factor 1 |
chr3_+_94954075 | 1.47 |
ENSMUST00000107260.2
ENSMUST00000142311.1 ENSMUST00000137088.1 ENSMUST00000152869.1 ENSMUST00000107254.1 ENSMUST00000107253.1 |
Rfx5
|
regulatory factor X, 5 (influences HLA class II expression) |
chr9_+_20868628 | 1.46 |
ENSMUST00000043911.7
|
A230050P20Rik
|
RIKEN cDNA A230050P20 gene |
chr3_+_137671524 | 1.43 |
ENSMUST00000166899.2
|
Gm21962
|
predicted gene, 21962 |
chr10_+_13966268 | 1.43 |
ENSMUST00000015645.4
|
Hivep2
|
human immunodeficiency virus type I enhancer binding protein 2 |
chr11_-_48871344 | 1.43 |
ENSMUST00000049519.3
|
Irgm1
|
immunity-related GTPase family M member 1 |
chr11_+_49050733 | 1.39 |
ENSMUST00000102785.1
|
Olfr56
|
olfactory receptor 56 |
chr6_+_29529277 | 1.38 |
ENSMUST00000163511.1
|
Irf5
|
interferon regulatory factor 5 |
chr10_+_39612934 | 1.36 |
ENSMUST00000019987.6
|
Traf3ip2
|
TRAF3 interacting protein 2 |
chr13_+_74639866 | 1.34 |
ENSMUST00000169114.1
|
Erap1
|
endoplasmic reticulum aminopeptidase 1 |
chr1_+_58505135 | 1.31 |
ENSMUST00000160947.1
ENSMUST00000129740.2 ENSMUST00000139825.1 |
Gm15834
|
predicted gene 15834 |
chr16_+_24393350 | 1.30 |
ENSMUST00000038053.6
|
Lpp
|
LIM domain containing preferred translocation partner in lipoma |
chr13_-_23710714 | 1.30 |
ENSMUST00000091707.6
ENSMUST00000006787.7 ENSMUST00000091706.6 |
Hfe
|
hemochromatosis |
chr16_+_42907563 | 1.29 |
ENSMUST00000151244.1
ENSMUST00000114694.2 |
Zbtb20
|
zinc finger and BTB domain containing 20 |
chr16_+_35938470 | 1.28 |
ENSMUST00000114878.1
|
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr11_-_51857624 | 1.27 |
ENSMUST00000020655.7
ENSMUST00000109090.1 |
Phf15
|
PHD finger protein 15 |
chr2_-_132111440 | 1.24 |
ENSMUST00000128899.1
|
Slc23a2
|
solute carrier family 23 (nucleobase transporters), member 2 |
chr8_-_111338152 | 1.23 |
ENSMUST00000056157.7
ENSMUST00000120432.1 |
Mlkl
|
mixed lineage kinase domain-like |
chr18_+_61045139 | 1.22 |
ENSMUST00000025522.4
ENSMUST00000115274.1 |
Pdgfrb
|
platelet derived growth factor receptor, beta polypeptide |
chr17_+_43389436 | 1.21 |
ENSMUST00000113599.1
|
Gpr116
|
G protein-coupled receptor 116 |
chr1_+_132008285 | 1.21 |
ENSMUST00000146432.1
|
Elk4
|
ELK4, member of ETS oncogene family |
chr7_+_104244496 | 1.21 |
ENSMUST00000106854.1
ENSMUST00000143414.1 |
Trim34a
|
tripartite motif-containing 34A |
chr7_+_104244465 | 1.18 |
ENSMUST00000106848.1
|
Trim34a
|
tripartite motif-containing 34A |
chr5_-_120777628 | 1.17 |
ENSMUST00000044833.8
|
Oas3
|
2'-5' oligoadenylate synthetase 3 |
chr5_-_92348871 | 1.17 |
ENSMUST00000038816.6
ENSMUST00000118006.1 |
Cxcl10
|
chemokine (C-X-C motif) ligand 10 |
chr19_-_21472552 | 1.17 |
ENSMUST00000087600.3
|
Gda
|
guanine deaminase |
chr19_-_4477119 | 1.15 |
ENSMUST00000166191.1
|
Syt12
|
synaptotagmin XII |
chr11_-_83020788 | 1.14 |
ENSMUST00000038141.8
ENSMUST00000092838.4 |
Slfn8
|
schlafen 8 |
chr1_+_171018920 | 1.13 |
ENSMUST00000078825.4
|
Fcgr4
|
Fc receptor, IgG, low affinity IV |
chr10_+_128270546 | 1.13 |
ENSMUST00000105238.3
ENSMUST00000085708.2 |
Stat2
|
signal transducer and activator of transcription 2 |
chr1_-_78197112 | 1.11 |
ENSMUST00000087086.6
|
Pax3
|
paired box gene 3 |
chr10_-_94944578 | 1.11 |
ENSMUST00000099337.3
|
Plxnc1
|
plexin C1 |
chr5_-_120812484 | 1.11 |
ENSMUST00000125547.1
|
Oas1c
|
2'-5' oligoadenylate synthetase 1C |
chr17_+_86167777 | 1.09 |
ENSMUST00000097275.2
|
Prkce
|
protein kinase C, epsilon |
chr8_+_61928081 | 1.07 |
ENSMUST00000154398.1
ENSMUST00000093485.2 ENSMUST00000156980.1 ENSMUST00000070631.7 |
Ddx60
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 60 |
chr5_-_120812506 | 1.07 |
ENSMUST00000117193.1
ENSMUST00000130045.1 |
Oas1c
|
2'-5' oligoadenylate synthetase 1C |
chr8_-_84773381 | 1.06 |
ENSMUST00000109764.1
|
Nfix
|
nuclear factor I/X |
chr8_-_111337793 | 1.05 |
ENSMUST00000145862.1
|
Mlkl
|
mixed lineage kinase domain-like |
chr19_+_6164433 | 1.05 |
ENSMUST00000045042.7
|
Batf2
|
basic leucine zipper transcription factor, ATF-like 2 |
chr16_-_35939082 | 1.04 |
ENSMUST00000081933.7
ENSMUST00000114885.1 |
Dtx3l
|
deltex 3-like (Drosophila) |
chr8_+_127064107 | 1.04 |
ENSMUST00000162536.1
ENSMUST00000026921.6 ENSMUST00000162665.1 ENSMUST00000160766.1 ENSMUST00000162602.1 ENSMUST00000162531.1 ENSMUST00000160581.1 ENSMUST00000161355.1 ENSMUST00000159537.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr12_+_37242030 | 1.01 |
ENSMUST00000160390.1
|
Agmo
|
alkylglycerol monooxygenase |
chr7_+_104244449 | 1.00 |
ENSMUST00000106849.2
ENSMUST00000060315.5 |
Trim34a
|
tripartite motif-containing 34A |
chr1_+_85650008 | 0.99 |
ENSMUST00000054279.8
ENSMUST00000147552.1 ENSMUST00000153574.1 ENSMUST00000150967.1 |
Sp100
|
nuclear antigen Sp100 |
chr4_-_40239700 | 0.98 |
ENSMUST00000142055.1
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr1_-_78196832 | 0.97 |
ENSMUST00000004994.9
|
Pax3
|
paired box gene 3 |
chr12_+_90738201 | 0.97 |
ENSMUST00000181874.1
|
Gm26512
|
predicted gene, 26512 |
chr16_+_8470763 | 0.95 |
ENSMUST00000046470.9
ENSMUST00000150790.1 ENSMUST00000142899.1 |
Mettl22
|
methyltransferase like 22 |
chr3_+_66981352 | 0.95 |
ENSMUST00000162036.1
|
Rsrc1
|
arginine/serine-rich coiled-coil 1 |
chr1_+_85649988 | 0.95 |
ENSMUST00000155094.1
|
Sp100
|
nuclear antigen Sp100 |
chr15_-_76243401 | 0.95 |
ENSMUST00000165738.1
ENSMUST00000075689.6 |
Parp10
|
poly (ADP-ribose) polymerase family, member 10 |
chr19_-_6084873 | 0.95 |
ENSMUST00000160977.1
ENSMUST00000159859.1 |
Zfpl1
|
zinc finger like protein 1 |
chr4_-_40239779 | 0.94 |
ENSMUST00000037907.6
|
Ddx58
|
DEAD (Asp-Glu-Ala-Asp) box polypeptide 58 |
chr13_+_42866247 | 0.93 |
ENSMUST00000131942.1
|
Phactr1
|
phosphatase and actin regulator 1 |
chr16_+_35938972 | 0.93 |
ENSMUST00000023622.6
ENSMUST00000114877.1 |
Parp9
|
poly (ADP-ribose) polymerase family, member 9 |
chr1_-_170110491 | 0.92 |
ENSMUST00000027985.2
|
Ddr2
|
discoidin domain receptor family, member 2 |
chr12_+_37241633 | 0.92 |
ENSMUST00000049874.7
|
Agmo
|
alkylglycerol monooxygenase |
chr6_+_39381175 | 0.90 |
ENSMUST00000031986.4
|
Rab19
|
RAB19, member RAS oncogene family |
chr16_-_44139630 | 0.87 |
ENSMUST00000137557.1
ENSMUST00000147025.1 |
Atp6v1a
|
ATPase, H+ transporting, lysosomal V1 subunit A |
chr2_-_173276144 | 0.87 |
ENSMUST00000139306.1
|
Pmepa1
|
prostate transmembrane protein, androgen induced 1 |
chr18_+_37400845 | 0.87 |
ENSMUST00000057228.1
|
Pcdhb9
|
protocadherin beta 9 |
chr14_+_55604550 | 0.85 |
ENSMUST00000138037.1
|
Irf9
|
interferon regulatory factor 9 |
chr11_+_43474276 | 0.85 |
ENSMUST00000173002.1
ENSMUST00000057679.3 |
C1qtnf2
|
C1q and tumor necrosis factor related protein 2 |
chr4_+_45972233 | 0.85 |
ENSMUST00000102929.1
|
Tdrd7
|
tudor domain containing 7 |
chr9_+_118478344 | 0.82 |
ENSMUST00000035020.8
|
Eomes
|
eomesodermin homolog (Xenopus laevis) |
chr14_-_63543931 | 0.82 |
ENSMUST00000058679.5
|
Mtmr9
|
myotubularin related protein 9 |
chr6_-_125231772 | 0.80 |
ENSMUST00000043422.7
|
Tapbpl
|
TAP binding protein-like |
chr7_+_104300230 | 0.78 |
ENSMUST00000106847.1
|
Trim34b
|
tripartite motif-containing 34B |
chr18_-_39490649 | 0.78 |
ENSMUST00000115567.1
|
Nr3c1
|
nuclear receptor subfamily 3, group C, member 1 |
chr2_-_84743655 | 0.77 |
ENSMUST00000181711.1
|
Gm19426
|
predicted gene, 19426 |
chr1_+_180942500 | 0.77 |
ENSMUST00000159436.1
|
Tmem63a
|
transmembrane protein 63a |
chr14_+_48446128 | 0.77 |
ENSMUST00000124720.1
|
Tmem260
|
transmembrane protein 260 |
chr4_+_138972885 | 0.76 |
ENSMUST00000123636.1
ENSMUST00000043042.3 ENSMUST00000050949.2 |
Tmco4
|
transmembrane and coiled-coil domains 4 |
chr7_+_44836286 | 0.76 |
ENSMUST00000033015.7
|
Il4i1
|
interleukin 4 induced 1 |
chr1_+_85650044 | 0.76 |
ENSMUST00000066427.4
|
Sp100
|
nuclear antigen Sp100 |
chr11_-_83020722 | 0.76 |
ENSMUST00000108152.2
|
Slfn8
|
schlafen 8 |
chr8_+_127064022 | 0.75 |
ENSMUST00000160272.1
ENSMUST00000079777.5 ENSMUST00000162907.1 |
Pard3
|
par-3 (partitioning defective 3) homolog (C. elegans) |
chr5_+_114896936 | 0.72 |
ENSMUST00000031542.9
ENSMUST00000146072.1 ENSMUST00000150361.1 |
Oasl2
|
2'-5' oligoadenylate synthetase-like 2 |
chr10_+_63061582 | 0.69 |
ENSMUST00000020266.8
ENSMUST00000178684.1 |
Pbld1
|
phenazine biosynthesis-like protein domain containing 1 |
chr19_+_12460749 | 0.68 |
ENSMUST00000081035.7
|
Mpeg1
|
macrophage expressed gene 1 |
chr1_+_143640664 | 0.68 |
ENSMUST00000038252.2
|
B3galt2
|
UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2 |
chr7_-_46795881 | 0.67 |
ENSMUST00000107653.1
ENSMUST00000107654.1 ENSMUST00000014562.7 ENSMUST00000152759.1 |
Hps5
|
Hermansky-Pudlak syndrome 5 homolog (human) |
chr4_+_94739518 | 0.66 |
ENSMUST00000071168.5
|
Tek
|
endothelial-specific receptor tyrosine kinase |
chr9_+_32116040 | 0.64 |
ENSMUST00000174641.1
|
Arhgap32
|
Rho GTPase activating protein 32 |
chr5_-_90223923 | 0.63 |
ENSMUST00000118816.1
ENSMUST00000048363.7 |
Cox18
|
cytochrome c oxidase assembly protein 18 |
chr5_-_120907510 | 0.62 |
ENSMUST00000080322.7
|
Oas1a
|
2'-5' oligoadenylate synthetase 1A |
chr6_+_57580992 | 0.60 |
ENSMUST00000031817.8
|
Herc6
|
hect domain and RLD 6 |
chr1_-_173912904 | 0.60 |
ENSMUST00000009340.8
|
Mnda
|
myeloid cell nuclear differentiation antigen |
chr7_-_46795661 | 0.60 |
ENSMUST00000123725.1
|
Hps5
|
Hermansky-Pudlak syndrome 5 homolog (human) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.4 | 13.6 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
3.3 | 10.0 | GO:2000547 | regulation of dendritic cell dendrite assembly(GO:2000547) |
2.7 | 8.0 | GO:1990166 | protein localization to site of double-strand break(GO:1990166) |
2.1 | 6.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.9 | 5.7 | GO:1904933 | regulation of cell proliferation in midbrain(GO:1904933) |
1.3 | 5.2 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
1.1 | 2.1 | GO:0002589 | regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002589) |
1.0 | 3.1 | GO:0009258 | 10-formyltetrahydrofolate catabolic process(GO:0009258) folic acid-containing compound catabolic process(GO:0009397) pteridine-containing compound catabolic process(GO:0042560) |
1.0 | 4.2 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
1.0 | 3.0 | GO:1900245 | positive regulation of MDA-5 signaling pathway(GO:1900245) |
1.0 | 4.9 | GO:0046967 | cytosol to ER transport(GO:0046967) |
1.0 | 3.8 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.9 | 5.7 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 1.9 | GO:0002481 | antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) |
0.9 | 23.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.8 | 3.3 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.8 | 3.1 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.7 | 3.3 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.7 | 3.9 | GO:1900142 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) regulation of trophectodermal cell proliferation(GO:1904073) positive regulation of trophectodermal cell proliferation(GO:1904075) |
0.6 | 5.8 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.6 | 3.7 | GO:0035549 | interferon-beta secretion(GO:0035546) regulation of interferon-beta secretion(GO:0035547) positive regulation of interferon-beta secretion(GO:0035549) |
0.6 | 3.7 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
0.6 | 9.3 | GO:0031000 | response to caffeine(GO:0031000) |
0.6 | 7.9 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.5 | 1.6 | GO:0048698 | negative regulation of collateral sprouting in absence of injury(GO:0048698) |
0.5 | 3.0 | GO:1900170 | negative regulation of glucocorticoid mediated signaling pathway(GO:1900170) |
0.5 | 3.8 | GO:1990504 | dense core granule exocytosis(GO:1990504) |
0.4 | 16.3 | GO:0035456 | response to interferon-beta(GO:0035456) |
0.4 | 1.2 | GO:0070904 | L-ascorbic acid transport(GO:0015882) transepithelial L-ascorbic acid transport(GO:0070904) |
0.4 | 1.2 | GO:0072276 | cell migration involved in vasculogenesis(GO:0035441) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 1.2 | GO:0046098 | guanine metabolic process(GO:0046098) |
0.4 | 1.9 | GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.4 | 2.9 | GO:0051138 | positive regulation of NK T cell differentiation(GO:0051138) |
0.4 | 2.1 | GO:0021853 | cerebral cortex GABAergic interneuron migration(GO:0021853) interneuron migration(GO:1904936) |
0.3 | 1.0 | GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation(GO:0060809) |
0.3 | 1.8 | GO:0003383 | apical constriction(GO:0003383) |
0.3 | 1.2 | GO:1901740 | negative regulation of myoblast fusion(GO:1901740) |
0.3 | 4.6 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.3 | 2.2 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
0.3 | 1.1 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.3 | 2.0 | GO:0015961 | diadenosine polyphosphate catabolic process(GO:0015961) |
0.2 | 11.7 | GO:0048247 | lymphocyte chemotaxis(GO:0048247) |
0.2 | 8.7 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.2 | 0.7 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 3.5 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.2 | 1.7 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.6 | GO:0007208 | phospholipase C-activating serotonin receptor signaling pathway(GO:0007208) |
0.2 | 3.6 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.2 | 2.1 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.2 | 4.5 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.2 | 0.6 | GO:1902867 | negative regulation of neural retina development(GO:0061076) negative regulation of retina development in camera-type eye(GO:1902867) negative regulation of amacrine cell differentiation(GO:1902870) |
0.2 | 1.7 | GO:0045078 | positive regulation of interferon-gamma biosynthetic process(GO:0045078) |
0.2 | 6.6 | GO:1901522 | positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus(GO:1901522) |
0.2 | 0.5 | GO:0048687 | positive regulation of sprouting of injured axon(GO:0048687) positive regulation of axon extension involved in regeneration(GO:0048691) |
0.2 | 1.2 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.2 | 0.5 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
0.2 | 1.8 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.2 | 5.2 | GO:0046688 | response to copper ion(GO:0046688) |
0.2 | 2.6 | GO:0010623 | programmed cell death involved in cell development(GO:0010623) |
0.1 | 1.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.1 | 1.1 | GO:0071357 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.1 | 1.5 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
0.1 | 0.9 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
0.1 | 1.8 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.1 | 0.9 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.6 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.4 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
0.1 | 1.2 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 4.9 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 1.9 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 0.5 | GO:1900226 | negative regulation of NLRP3 inflammasome complex assembly(GO:1900226) |
0.1 | 2.4 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.1 | 1.7 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 10.4 | GO:0007586 | digestion(GO:0007586) |
0.1 | 5.0 | GO:0006687 | glycosphingolipid metabolic process(GO:0006687) |
0.1 | 0.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.1 | 0.5 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.1 | 2.7 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.1 | 0.3 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.2 | GO:0061386 | closure of optic fissure(GO:0061386) negative regulation of integrin-mediated signaling pathway(GO:2001045) |
0.1 | 1.1 | GO:0021707 | cerebellar granular layer formation(GO:0021684) cerebellar granule cell differentiation(GO:0021707) |
0.1 | 0.2 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.1 | 1.1 | GO:0042119 | neutrophil activation(GO:0042119) |
0.1 | 0.5 | GO:0048207 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
0.0 | 1.0 | GO:0042832 | defense response to protozoan(GO:0042832) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 5.9 | GO:0019395 | fatty acid oxidation(GO:0019395) |
0.0 | 0.2 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.0 | 1.9 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.0 | 3.1 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.0 | 1.5 | GO:0034341 | response to interferon-gamma(GO:0034341) |
0.0 | 0.4 | GO:0021678 | third ventricle development(GO:0021678) |
0.0 | 0.3 | GO:0002862 | negative regulation of inflammatory response to antigenic stimulus(GO:0002862) |
0.0 | 0.1 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
0.0 | 0.9 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.1 | GO:0043974 | histone H3-K27 acetylation(GO:0043974) leukemia inhibitory factor signaling pathway(GO:0048861) regulation of histone H3-K27 acetylation(GO:1901674) |
0.0 | 1.1 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.0 | 1.0 | GO:0046677 | response to antibiotic(GO:0046677) |
0.0 | 0.2 | GO:0060124 | positive regulation of growth hormone secretion(GO:0060124) |
0.0 | 0.5 | GO:0032689 | negative regulation of interferon-gamma production(GO:0032689) |
0.0 | 0.3 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.5 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.0 | 1.3 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.0 | 0.3 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.0 | 2.7 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 1.8 | GO:0007286 | spermatid development(GO:0007286) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 12.7 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
0.7 | 5.5 | GO:0042825 | TAP complex(GO:0042825) |
0.4 | 3.9 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) insulin-like growth factor ternary complex(GO:0042567) |
0.4 | 2.1 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
0.4 | 3.2 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.3 | 1.3 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.3 | 13.6 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.2 | 1.8 | GO:0033269 | internode region of axon(GO:0033269) |
0.2 | 3.3 | GO:0044754 | autolysosome(GO:0044754) |
0.2 | 1.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.2 | 6.5 | GO:0035861 | site of double-strand break(GO:0035861) |
0.1 | 6.5 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 5.2 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
0.1 | 0.1 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.1 | 3.3 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 8.1 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 0.9 | GO:0033391 | chromatoid body(GO:0033391) |
0.0 | 3.1 | GO:0005776 | autophagosome(GO:0005776) |
0.0 | 2.0 | GO:0005637 | nuclear inner membrane(GO:0005637) |
0.0 | 3.8 | GO:0042734 | presynaptic membrane(GO:0042734) |
0.0 | 6.3 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 53.5 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 6.5 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 12.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.0 | 0.6 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.2 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 1.0 | GO:0032587 | ruffle membrane(GO:0032587) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 5.1 | GO:0003692 | left-handed Z-DNA binding(GO:0003692) |
1.6 | 6.3 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
1.5 | 6.0 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.5 | 14.7 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
1.4 | 5.8 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
1.2 | 3.5 | GO:0050479 | glyceryl-ether monooxygenase activity(GO:0050479) |
1.1 | 3.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
1.0 | 3.1 | GO:0016155 | formyltetrahydrofolate dehydrogenase activity(GO:0016155) |
1.0 | 4.9 | GO:0046980 | peptide antigen-transporting ATPase activity(GO:0015433) tapasin binding(GO:0046980) |
0.9 | 3.6 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.9 | 8.0 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.8 | 9.3 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.7 | 2.1 | GO:0019153 | protein-disulfide reductase (glutathione) activity(GO:0019153) |
0.7 | 6.6 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.6 | 3.7 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.6 | 3.0 | GO:0004883 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
0.5 | 1.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
0.5 | 5.2 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.5 | 5.2 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.5 | 1.5 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.5 | 2.0 | GO:0047710 | bis(5'-adenosyl)-triphosphatase activity(GO:0047710) |
0.5 | 16.9 | GO:0008009 | chemokine activity(GO:0008009) |
0.4 | 3.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.4 | 1.2 | GO:0070890 | L-ascorbate:sodium symporter activity(GO:0008520) L-ascorbic acid transporter activity(GO:0015229) sodium-dependent L-ascorbate transmembrane transporter activity(GO:0070890) |
0.3 | 0.6 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.3 | 1.1 | GO:0035276 | ethanol binding(GO:0035276) |
0.3 | 5.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.3 | 0.8 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.2 | 1.2 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
0.2 | 1.9 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.9 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.2 | 0.7 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.1 | 1.3 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.1 | 1.3 | GO:0039706 | co-receptor binding(GO:0039706) |
0.1 | 2.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.1 | 25.7 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 3.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.1 | 0.9 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.1 | 2.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 4.2 | GO:0043531 | ADP binding(GO:0043531) |
0.1 | 0.5 | GO:0005030 | neurotrophin receptor activity(GO:0005030) |
0.1 | 1.1 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.1 | 0.5 | GO:0033142 | progesterone receptor binding(GO:0033142) |
0.1 | 2.0 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.3 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 5.5 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 19.0 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 1.6 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
0.1 | 6.9 | GO:0020037 | heme binding(GO:0020037) |
0.1 | 2.1 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.0 | 0.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.6 | GO:0051378 | serotonin binding(GO:0051378) |
0.0 | 0.2 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.0 | 9.1 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 1.8 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 2.7 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 4.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.1 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.0 | 0.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 2.7 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 1.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.1 | GO:0004520 | endodeoxyribonuclease activity(GO:0004520) |
0.0 | 2.6 | GO:0036459 | thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
0.0 | 2.8 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.2 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.0 | 3.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.0 | 0.9 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 6.3 | GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding(GO:0000978) |
0.0 | 0.4 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 1.0 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 2.7 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.0 | 0.5 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.6 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.0 | 0.2 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.0 | 3.1 | GO:0001047 | core promoter binding(GO:0001047) |
0.0 | 1.9 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 1.0 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.2 | 4.6 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 15.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 11.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.1 | 6.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.1 | 5.8 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.9 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 1.7 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.1 | 3.9 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.1 | 1.8 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.1 | 6.2 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 5.2 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 5.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 12.5 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 2.3 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 2.1 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.2 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 2.0 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 1.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.0 | 0.8 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 5.0 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.9 | PID AURORA A PATHWAY | Aurora A signaling |
0.0 | 0.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.0 | 2.8 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 1.0 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.7 | PID TRKR PATHWAY | Neurotrophic factor-mediated Trk receptor signaling |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.8 | 9.3 | REACTOME DEFENSINS | Genes involved in Defensins |
0.6 | 1.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.3 | 4.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.3 | 6.3 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.3 | 6.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.3 | 12.7 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.3 | 4.9 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.2 | 5.6 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.2 | 3.2 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.2 | 7.5 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.1 | 4.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 5.2 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.1 | 5.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.1 | 9.6 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.1 | 2.7 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 1.8 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.1 | 0.8 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.8 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.1 | 1.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 0.6 | REACTOME SEROTONIN RECEPTORS | Genes involved in Serotonin receptors |
0.0 | 1.3 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 1.1 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.1 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.7 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 1.2 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.0 | 0.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.0 | 1.2 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.5 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 1.2 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.0 | 2.1 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 0.1 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |